Journal article
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia
Abstract
The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare side effect of adenoviral vector vaccines against coronavirus disease 2019 (Covid-19). We describe the response to IVIG therapy in three of the first patients in whom VITT was identified in Canada after the receipt of the ChAdOx1 nCoV-19 vaccine. The patients were …
Authors
Bourguignon A; Arnold DM; Warkentin TE; Smith JW; Pannu T; Shrum JM; Al Maqrashi ZAA; Shroff A; Lessard M-C; Blais N
Journal
The New England Journal of Medicine, Vol. 385, No. 8, pp. 720–728
Publisher
Massachusetts Medical Society
Publication Date
August 19, 2021
DOI
10.1056/nejmoa2107051
ISSN
0028-4793